Ignite Creation Date:
2025-12-25 @ 4:49 AM
Ignite Modification Date:
2026-04-23 @ 5:56 PM
Study NCT ID:
NCT01022918
Status:
COMPLETED
Last Update Posted:
2012-09-25
First Post:
2009-11-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluation of the Irinotecan/Bevacizumab Association for Naive Unresectable Glioblastoma
Sponsor:
Centre Georges Francois Leclerc
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
TemAvIr
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None